Skip to main content

Febit Joins European Sequencing Technology Alliance

NEW YORK (GenomeWeb News) – Febit has joined a European consortium focused on developing DNA sequencing technologies, and plans to advance its gene capturing technology for use with the group's members.

The Revolutionary Approaches and Devices for Nucleic Acid analysis consortium, involving 16 industry and academic research entities and funded by the European Union with €12 million ($15.1 million), is focused on developing faster, more cost-efficient and targeted approaches in comparative genomics.

The HybSelect technology enables capture of specific DNA regions for high-throughput sequencing, allows researchers to operate next-generation sequencers by directing the sequencing process to the regions of interest to the researcher, Febit CSO Peer Stähler said in a statement.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.